Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingya Li

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Cell Death & Disease|January 27, 2021
MKL1-induced lncRNA SNHG18 drives the growth and metastasis of non-small cell lung cancer via the miR-211-5p/BRD4 axisHuijie Fan, Jing Yuan, Yaqing Li, et al.
Frontiers in Oncology|February 15, 2024
Efficacy of chemo-immunotherapy in metastatic <i>BRAF</i>-mutated lung cancer: a single-center retrospective dataNingning Yan, Huixian Zhang, Sanxing Guo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 15, 2020
LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expressionHuijie Fan, Jing Yuan, Xiangyu Li, et al.
Frontiers in Pharmacology|September 26, 2022
Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case reportNingning Yan, Siyuan Huang, Linlin Li, et al.
Frontiers in Pharmacology|August 14, 2023
Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case reportNingning Yan, Siyuan Huang, Linlin Li, et al.
Advances in Therapy|February 16, 2026
Treatment Patterns and Clinical Outcomes in Unresectable Stage III EGFR-Mutated Non-Small Cell Lung Cancer in ChinaShun Lu, Xingya Li, Changchun Wang, et al.
ACS Applied Materials & Interfaces|May 29, 2020
Effect of Anion Species on Ion Current Rectification Properties of Positively Charged NanochannelsChen Zhao, Huacheng Zhang, Jue Hou, et al.
Nature Communications|November 27, 2025
Porous organic cage mixed matrix membranes for efficient enantioseparationYifan Li, Zheng Liu, Daojiang Zhu, et al.
Frontiers in Oncology|May 6, 2024
Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatmentSiyuan Huang, Linlin Li, Ningning Yan, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|November 19, 2018
Comparison of Combination Stereotactic Body Radiotherapy Plus High-Intensity Focused Ultrasound Ablation Versus Stereotactic Body Radiotherapy Alone for Massive Hepatocellular CarcinomaLei Wang, Lingzhao Li, Xiaofang Wang, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Cell Death & Disease|January 27, 2021
MKL1-induced lncRNA SNHG18 drives the growth and metastasis of non-small cell lung cancer via the miR-211-5p/BRD4 axisHuijie Fan, Jing Yuan, Yaqing Li, et al.
Frontiers in Oncology|February 15, 2024
Efficacy of chemo-immunotherapy in metastatic <i>BRAF</i>-mutated lung cancer: a single-center retrospective dataNingning Yan, Huixian Zhang, Sanxing Guo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 15, 2020
LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expressionHuijie Fan, Jing Yuan, Xiangyu Li, et al.
Frontiers in Pharmacology|September 26, 2022
Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case reportNingning Yan, Siyuan Huang, Linlin Li, et al.
Frontiers in Pharmacology|August 14, 2023
Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case reportNingning Yan, Siyuan Huang, Linlin Li, et al.
Advances in Therapy|February 16, 2026
Treatment Patterns and Clinical Outcomes in Unresectable Stage III EGFR-Mutated Non-Small Cell Lung Cancer in ChinaShun Lu, Xingya Li, Changchun Wang, et al.
ACS Applied Materials & Interfaces|May 29, 2020
Effect of Anion Species on Ion Current Rectification Properties of Positively Charged NanochannelsChen Zhao, Huacheng Zhang, Jue Hou, et al.
Nature Communications|November 27, 2025
Porous organic cage mixed matrix membranes for efficient enantioseparationYifan Li, Zheng Liu, Daojiang Zhu, et al.
Frontiers in Oncology|May 6, 2024
Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatmentSiyuan Huang, Linlin Li, Ningning Yan, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|November 19, 2018
Comparison of Combination Stereotactic Body Radiotherapy Plus High-Intensity Focused Ultrasound Ablation Versus Stereotactic Body Radiotherapy Alone for Massive Hepatocellular CarcinomaLei Wang, Lingzhao Li, Xiaofang Wang, et al.
Pageof 15